Paramount Bed Holdings Co., Ltd.

パラマウントベッドホールディングス(株)

7817.T

Medical Instruments & Supplies

2026/02/09 Updated

Market Cap: $1.2B (¥197.1B)

Stock Price: $22.11 (¥3,515)

Exchange Rate: 1 USD = ¥158.98

Stock Price Chart

2026/02/09 Updated

0.00

PER (Price Earnings Ratio)

vs Industry Avg: -9.5

1.44

PBR (Price to Book Ratio)

vs Industry Avg: +0.2

2.79%

Dividend Yield

vs Industry Avg: -0.16%

Price Trend

2026/02/09 Updated

Short-term

5-Day MA

-100.00%

Near-term

25-Day MA

-100.00%

Mid-term

75-Day MA

-100.00%

Long-term

200-Day MA

-100.00%

Price & Trading Details

2026/02/09 Updated

PRICE

Previous Close ¥3,515

Open ¥3,515

High ¥3,515

Low ¥3,510

Close ¥3,515

TRADING

Volume 370,600

Average Volume 182,631

Turnover ¥13億

Min. Purchase ¥351,500

Analyst Recommendations 1 analysts

Updated 2026/04/01

Strong Buy

Buy

Hold

Sell

Strong Sell

Target Price (Mean)

¥2,700

Hold

¥-

High

¥2,700

Median

¥-

Low

-23% vs Current Price

This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/04/01

84.6%

Insider Holdings

23.4%

Institutional

0.0%

Public Float

Institutional Holders

Insider Holdings 84.6%

Institutional 23.4%

Public Float 0.0%

Major Holders

Updated 2026/04/01

Institution	Ownership	Shares	Change
MFS International New Discovery Fund	2.39%	1.5M	+8.66%
Fidelity Series International Small Cap Fund	0.95%	586.6K	-4.87%
Vanguard International Stock Index-Total Intl Stock Indx	0.83%	512.7K	-0.60%
Transamerica International Small Cap Value Fd	0.63%	390.0K	+2.09%
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund	0.51%	317.3K	+1.15%
DFA Japanese Small Company Series	0.41%	253.0K	0.00%

Dividend History

Updated 2026/04/05

Dividend Yield

¥49

Annual Dividend

-40.2%

YoY Growth

Payout Ratio

Year	Dividend	Change
2025	¥49	-40.2%
2024	¥82	+32.3%
2023	¥62	+8.8%
2022	¥57	+8.6%
2021	¥53	-

Financial Performance

2026/04/05 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

	2022	2023	2024	2025
Income Statement
Revenue	¥90,352M	¥99,009M	¥106,016M	¥108,583M
Gross Profit	¥43,031M	¥47,202M	¥50,632M	¥52,558M
Operating Income	¥12,340M	¥13,453M	¥13,819M	¥12,977M
Pretax Income	¥13,526M	¥13,906M	¥15,618M	¥12,998M
Net Income	¥9,092M	¥9,215M	¥10,622M	¥9,083M
EPS	¥156.39	¥158.37	¥182.61	-
Operating Margin	13.66%	13.59%	13.03%	11.95%
Balance Sheet
Total Assets	¥164,281M	¥172,293M	¥180,020M	¥183,027M
Total Equity	¥121,674M	¥128,695M	¥136,014M	¥137,282M
Total Liabilities	¥42,607M	¥43,598M	¥44,006M	¥45,745M
Cash	¥39,672M	¥39,820M	¥33,828M	¥34,943M
Interest-bearing Debt	¥6,135M	¥5,507M	¥5,964M	¥6,805M
Equity Ratio	74.06%	74.70%	75.55%	75.01%
D/E Ratio	0.05	0.04	0.04	0.05
Cash Flow
Operating CF	¥7,822M	¥9,151M	¥7,521M	¥10,045M
Investing CF	-¥220M	-¥6,332M	-¥8,163M	¥264M
Financing CF	-¥3,365M	-¥3,232M	-¥5,969M	-¥8,804M
Free CF	¥6,301M	¥5,349M	¥3,286M	¥5,986M
Efficiency
ROE	7.47%	7.16%	7.81%	6.62%
ROA	5.53%	5.35%	5.90%	4.96%